Quarterly report pursuant to Section 13 or 15(d)

Significant Transactions (Summary of Asset Acquisition) (Details)

v3.23.1
Significant Transactions (Summary of Asset Acquisition) (Details) - USD ($)
Sep. 16, 2022
Aug. 23, 2021
Purchase price allocated   $ 7,500,000
RubrYc Therapeutics, Inc. [Member]    
Purchase price allocated $ 1,342,000  
Series A-2 Preferred Stock [Member]    
Purchase price allocated   1,760,000
Asset Acquisition Intangible Assets [Member]    
Purchase price allocated   4,300,000
Asset Acquisition Intangible Assets [Member] | RubrYc Therapeutics, Inc. [Member]    
Purchase price allocated 1,228,000  
Asset Acquisition Fixed Assets [Member] | RubrYc Therapeutics, Inc. [Member]    
Purchase price allocated $ 114,000  
Asset Acquisition Prepaid Expenses [Member]    
Purchase price allocated   $ 1,440,000